scholarly article | Q13442814 |
P2093 | author name string | Nanette Wenger | |
P2860 | cites work | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction | Q77725650 | ||
Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women | Q78772959 | ||
Hypertension in women | Q87312340 | ||
Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 | ||
Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association | Q22306361 | ||
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials | Q28194551 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women | Q28218670 | ||
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 | ||
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial | Q29615226 | ||
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
Delivery of a small for gestational age infant and greater maternal risk of ischemic heart disease | Q31052158 | ||
Physical activity and risk for cardiovascular events in diabetic women | Q31933633 | ||
Late cardiovascular consequences of gestational diabetes mellitus | Q33687575 | ||
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
Early or recurrent preterm birth and maternal cardiovascular disease risk | Q33980951 | ||
Hypertension in women: part I. | Q34058743 | ||
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. | Q34251047 | ||
Meta-analysis of statin effects in women versus men. | Q34251483 | ||
Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations | Q34287536 | ||
Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus | Q34343906 | ||
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society | Q34384547 | ||
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement | Q34521526 | ||
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. | Q34543330 | ||
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study | Q34585945 | ||
Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline | Q34631457 | ||
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q34657387 | ||
Prevalence of depression in survivors of acute myocardial infarction. | Q34704102 | ||
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
Value of exercise treadmill testing in women | Q34754980 | ||
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review | Q34812877 | ||
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events | Q35021821 | ||
Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review | Q35090266 | ||
Depression, mortality, and medical morbidity in patients with coronary heart disease | Q35189639 | ||
Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study | Q35379591 | ||
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort | Q35553113 | ||
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women | Q35721814 | ||
Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children | Q35882065 | ||
Hypertension: trends in prevalence, incidence, and control | Q36419526 | ||
Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort | Q36811755 | ||
Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control study | Q36854224 | ||
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus | Q36968832 | ||
Cardiovascular disease risk factors in polycystic ovary syndrome | Q37052782 | ||
Psychological status during recovery from an acute heart attack | Q51316979 | ||
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. | Q51369167 | ||
Gender differences in the management and clinical outcome of stable angina. | Q51820934 | ||
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. | Q51922378 | ||
Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women. | Q52371600 | ||
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. | Q55053962 | ||
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | Q55055148 | ||
A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index) | Q56928615 | ||
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert | Q57135112 | ||
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Q57413870 | ||
Gestational Diabetes Mellitus Increases the Risk of Cardiovascular Disease in Women With a Family History of Type 2 Diabetes | Q58037097 | ||
Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes | Q59664260 | ||
Exercise treadmill score for predicting prognosis in coronary artery disease | Q69011385 | ||
Exercise echocardiographic detection of coronary artery disease in women | Q69787248 | ||
Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception | Q71396287 | ||
Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women | Q71870033 | ||
Contraceptive hormone use and cardiovascular disease | Q37138852 | ||
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study | Q37147440 | ||
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population | Q37396518 | ||
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis | Q37493828 | ||
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association | Q37499363 | ||
Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults | Q37597000 | ||
Failure of fertility therapy and subsequent adverse cardiovascular events | Q37712334 | ||
Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies | Q37916895 | ||
Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement | Q38054601 | ||
Recognizing pregnancy-associated cardiovascular risk factors | Q38159827 | ||
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association | Q38190806 | ||
Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. | Q38194709 | ||
Pre-eclampsia and future cardiovascular risk among women: a review | Q38194737 | ||
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events | Q38214530 | ||
Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association | Q38232312 | ||
Oral contraceptives and the risk of myocardial infarction | Q38491037 | ||
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). | Q40145477 | ||
Epidemiology of women and depression | Q40599444 | ||
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. | Q43497544 | ||
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease | Q43826616 | ||
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group | Q44137448 | ||
Blood pressure levels in the 41 populations of the WHO MONICA Project | Q44236419 | ||
Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome | Q44467041 | ||
Screening, referral and treatment for depression in patients with coronary heart disease | Q44499517 | ||
The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis | Q44558171 | ||
Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women | Q45248528 | ||
Stress echocardiography in the evaluation of women presenting with chest pain syndrome: a randomized, prospective comparison with electrocardiographic stress testing. | Q46463451 | ||
Screening women with polycystic ovary syndrome for metabolic syndrome | Q46580864 | ||
Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits | Q46765359 | ||
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome | Q46774573 | ||
Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study | Q47320684 | ||
Long-term cardiovascular risk in women prescribed fertility therapy | Q48441287 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e201701 | |
P577 | publication date | 2017-03-31 | |
P1433 | published in | Global cardiology science & practice | Q27725398 |
P1476 | title | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. | |
P478 | volume | 2017 |